CHEK1 and ovarian carcinoma: To this end, we performed a genome-wide CRISPR knockout screen in the ovarian cancer-derived cell line OVCAR8 and measured the effect of individual gene knockouts on cell viability following treatment with the CHK1/2 checkpoint kinase inhibitor Prexasertib over 10 cell generations.